The House of Representatives last night voted 258-101 to pass the Synthetic Drug Control Act (H.R. 3537). The AHA-supported legislation would give the Drug Enforcement Administration authority to stop the distribution, sale and use of additional synthetic drugs by classifying them as Schedule I controlled substances. Since 2012, when 26 types of synthetic drugs were added to Schedule I, “many new synthetic substances have entered the market, leading to devastating health consequences and increased mortality, particularly among the nation’s youth,” AHA noted last year in a letter of support for the bill.